IMAGIO® | AI-based decision support
Clinical decision support for reading Imagio®
AI-based SenoGram®, only available with the Imagio® System, assists radiologists in objectively assigning the probability of malignancy, providing greater accuracy in distinguishing benign from malignant masses.
By providing image reference keys to facilitate more accurate assignment of ultrasound and OA feature scores, the SenoGram® helps to objectively and precisely translate OA/US into an accurate and precise Likelihood Of Malignancy (LOM).
Getting Started
Access our brochures, ebook and when you're ready, schedule a demo.
Try an interactive SenoGram® demo
The new imaging modality to diagnose breast cancer in real-time.
Proven to make clinicians more accurate
In a multi-reader study, readers were more accurate in distinguishing benign from malignant masses when using the SenoGram® than they were with their subjective reads, achieving higher specificity at 98% sensitivity with SenoGram® decision support.1
Seno University
Seno University, an on-demand virtual learning platform, led by Breast Ultrasound expert, Dr. A. Thomas Stavros, to ensure users gain quick confidence with reading and assigning diagnostic BI-RADS.
References
- Seiler SJ, Neuschler EI, Butler RS, Lavin PT, Dogan BE. Optoacoustic imaging with decision support for differentiation of benign and malignant breast masses: A 15-reader retrospective study. AJR Am J Roentgenol. December 7, 2022.